Imaging standardisation in metastatic colorectal cancer: A joint EORTC-ESOI-ESGAR expert consensus recommendation.

Humans Consensus Artificial Intelligence Reproducibility of Results Rectal Neoplasms Colonic Neoplasms
Artificial intelligence Colorectal cancer Computed tomography Imaging Positron emission tomography Radiomics Standardisation

Journal

European journal of cancer (Oxford, England : 1990)
ISSN: 1879-0852
Titre abrégé: Eur J Cancer
Pays: England
ID NLM: 9005373

Informations de publication

Date de publication:
11 2022
Historique:
received: 19 07 2022
revised: 13 09 2022
accepted: 14 09 2022
pubmed: 25 10 2022
medline: 22 11 2022
entrez: 24 10 2022
Statut: ppublish

Résumé

Treatment monitoring in metastatic colorectal cancer (mCRC) relies on imaging to evaluate the tumour burden. Response Evaluation Criteria in Solid Tumors provide a framework on reporting and interpretation of imaging findings yet offer no guidance on a standardised imaging protocol tailored to patients with mCRC. Imaging protocol heterogeneity remains a challenge for the reproducibility of conventional imaging end-points and is an obstacle for research on novel imaging end-points. Acknowledging the recently highlighted potential of radiomics and artificial intelligence tools as decision support for patient care in mCRC, a multidisciplinary, international and expert panel of imaging specialists was formed to find consensus on mCRC imaging protocols using the Delphi method. Under the guidance of the European Organisation for Research and Treatment of Cancer (EORTC) Imaging and Gastrointestinal Tract Cancer Groups, the European Society of Oncologic Imaging (ESOI) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the EORTC-ESOI-ESGAR core imaging protocol was identified. This consensus protocol attempts to promote standardisation and to diminish variations in patient preparation, scan acquisition and scan reconstruction. We anticipate that this standardisation will increase reproducibility of radiomics and artificial intelligence studies and serve as a catalyst for future research on imaging end-points. For ongoing and future mCRC trials, we encourage principal investigators to support the dissemination of these imaging standards across recruiting centres.

Sections du résumé

BACKGROUND
Treatment monitoring in metastatic colorectal cancer (mCRC) relies on imaging to evaluate the tumour burden. Response Evaluation Criteria in Solid Tumors provide a framework on reporting and interpretation of imaging findings yet offer no guidance on a standardised imaging protocol tailored to patients with mCRC. Imaging protocol heterogeneity remains a challenge for the reproducibility of conventional imaging end-points and is an obstacle for research on novel imaging end-points.
PATIENTS AND METHODS
Acknowledging the recently highlighted potential of radiomics and artificial intelligence tools as decision support for patient care in mCRC, a multidisciplinary, international and expert panel of imaging specialists was formed to find consensus on mCRC imaging protocols using the Delphi method.
RESULTS
Under the guidance of the European Organisation for Research and Treatment of Cancer (EORTC) Imaging and Gastrointestinal Tract Cancer Groups, the European Society of Oncologic Imaging (ESOI) and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR), the EORTC-ESOI-ESGAR core imaging protocol was identified.
CONCLUSION
This consensus protocol attempts to promote standardisation and to diminish variations in patient preparation, scan acquisition and scan reconstruction. We anticipate that this standardisation will increase reproducibility of radiomics and artificial intelligence studies and serve as a catalyst for future research on imaging end-points. For ongoing and future mCRC trials, we encourage principal investigators to support the dissemination of these imaging standards across recruiting centres.

Identifiants

DOI: 10.1016/j.ejca.2022.09.012 PMID: 36274570
pubmed: 36274570
pii: S0959-8049(22)00751-1
doi: 10.1016/j.ejca.2022.09.012
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

193-206

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: K.H. reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from Y-mAbs, all outside the submitted work. L.B. is a cofounder of Collective Minds Radiology. R.C. reports travel support by Bracco Imaging. T.D. reports honorary fees and travel support by Siemens, Canon, Bayer, b.e. imaging and research grants by Siemens Healthineers, Bayer, Guerbet and b.e. imaging. E.L. reports receiving research grants from AIRC and from the Italian Ministry of Health, and faculty remuneration from ESMIT (European School of Multimodality Imaging and Therapy) and MI&T Congressi. D.E.O.-L. received expert remuneration from EAU for participating in PET PSMA Consensus Meeting in January 2022. The remaining authors declare that they have no conflict of interest related to this study. W.G.K. reports personal fees from Bristol-Myers Squibb.

Auteurs

Marcus Unterrainer (M)

Department of Radiology, University Hospital, LMU Munich, Munich, Germany; Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium. Electronic address: https://twitter.com/@LMU_Radiology.

Christophe M Deroose (CM)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Nuclear Medicine, University Hospitals Leuven, Leuven, Belgium. Electronic address: https://twitter.com/@deroose_c.

Ken Herrmann (K)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Gastrointestinal Tract Cancer Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany. Electronic address: https://twitter.com/@ProfKHerrmann.

Markus Moehler (M)

Gastrointestinal Tract Cancer Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Medicine, Johannes Gutenberg-University Clinic, University of Mainz, Mainz, Germany.

Lennart Blomqvist (L)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden; Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden.

Roberto Cannella (R)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria; Section of Radiology - Department of Biomedicine, Neuroscience and Advanced Diagnostics (BiND), University Hospital "Paolo Giaccone", Via Del Vespro 129, Palermo 90127, Italy; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Via Del Vespro, 129, 90127 Palermo, Italy.

Caroline Caramella (C)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, Groupe Hospitalier Paris Saint-Joseph, Paris, Île-de-France, France. Electronic address: https://twitter.com/@CCaramellaCICT.

Damiano Caruso (D)

European Society of Oncologic Imaging (ESOI), European Society of Radiology, Vienna, Austria; Department of Medical Surgical Sciences and Translational Medicine, Sapienza - University of Rome, Radiology Unit - Sant'Andrea University Hospital, Italy. Electronic address: https://twitter.com/@MdDamians.

Manil D Chouhan (MD)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Division of Medicine, Centre for Medical Imaging, University College London (UCL), London, UK. Electronic address: https://twitter.com/@DrManil_Rad.

Timm Denecke (T)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Diagnostic and Interventional Radiology, University Hospital Leipzig, Leipzig, Germany.

Carolina De la Pinta (C)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Radiation Oncology Department, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain.

Lioe-Fee De Geus-Oei (LF)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands; Biomedical Photonic Imaging Group, University of Twente, Enschede, the Netherlands.

Audrius Dulskas (A)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Abdominal and General Surgery and Oncology, National Cancer Institute, Vilnius, Lithuania.

Michel Eisenblätter (M)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, University Hospital Freiburg, Freiburg, Germany.

Kieran G Foley (KG)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria; Division of Cancer & Genetics, School of Medicine, Cardiff University, UK.

Sofia Gourtsoyianni (S)

European Society of Oncologic Imaging (ESOI), European Society of Radiology, Vienna, Austria; European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria; 1st Department of Radiology, School of Medicine, National and Kapodistrian University of Athens, Areteion Hospital, Athens, Greece.

Frederic E Lecouvet (FE)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, Institut de Recherche Expérimentale et Clinique (IREC), Cliniques Universitaires Saint Luc, Université Catholique de Louvain (UCLouvain), Brussels, Belgium.

Egesta Lopci (E)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Nuclear Medicine, IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano (MI), Italy. Electronic address: https://twitter.com/@LopciEgesta.

Monique Maas (M)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

Markus M Obmann (MM)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria; Clinic of Radiology and Nuclear Imaging, University Hospital Basel, Petersgraben 4, 4051 Basel, Switzerland. Electronic address: https://twitter.com/@Doc_X_Ray.

Daniela E Oprea-Lager (DE)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, VU Medical Center, Amsterdam, the Netherlands.

Joost J C Verhoeff (JJC)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: https://twitter.com/@joostverhoeff.

Ines Santiago (I)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, Champalimaud Foundation, Av. Brasília, 1400-038 Lisbon, Portugal.

Sylvain Terraz (S)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Unit of Interventional Radiology, Division of Radiology, Department of Diagnostics, University Hospitals of Geneva, Geneva, Switzerland.

Melvin D'Anastasi (M)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Medical Imaging Department, Mater Dei Hospital, University of Malta, Msida, Malta.

Daniele Regge (D)

European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria; Department of Surgical Sciences, University of Turin, Turin, 10124, Italy; Radiology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, 10060, Italy.

Andrea Laghi (A)

European Society of Oncologic Imaging (ESOI), European Society of Radiology, Vienna, Austria; European Society of Gastrointestinal and Abdominal Radiology (ESGAR), Vienna, Austria; Department of Radiology, Groupe Hospitalier Paris Saint-Joseph, Paris, Île-de-France, France. Electronic address: https://twitter.com/@Andrea_Laghi_MD.

Regina G H Beets-Tan (RGH)

Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Radiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: https://twitter.com/@rbeetstan.

Volker Heinemann (V)

Department of Medicine III, University Hospital, LMU Munich, Munich, Germany.

Florian Lordick (F)

Gastrointestinal Tract Cancer Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Medicine II and University Cancer Center Leipzig, University of Leipzig Medical Center, Leipzig, Germany. Electronic address: https://twitter.com/@FlorianLordick.

Elizabeth C Smyth (EC)

Gastrointestinal Tract Cancer Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. Electronic address: https://twitter.com/@LizzySmyth1.

Jens Ricke (J)

Department of Radiology, University Hospital, LMU Munich, Munich, Germany; Gastrointestinal Tract Cancer Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium.

Wolfgang G Kunz (WG)

Department of Radiology, University Hospital, LMU Munich, Munich, Germany; Imaging Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; Gastrointestinal Tract Cancer Group, European Organisation of Research and Treatment in Cancer (EORTC), Brussels, Belgium; European Society of Oncologic Imaging (ESOI), European Society of Radiology, Vienna, Austria. Electronic address: wolfgang.kunz@med.lmu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Imaging standardisation in metastatic...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Imaging standardisation in metastatic...
questionsmedicales.fr › Sciences de l'information › Méthodologies informatiques › Algorithmes › Intelligence artificielle › Imaging standardisation in metastatic...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Reproductibilité des résultats › Imaging standardisation in metastatic...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Maladies du rectum › Tumeurs colorectales › Tumeurs du rectum › Imaging standardisation in metastatic...
questionsmedicales.fr › Maladies de l'appareil digestif › Maladies gastro-intestinales › Maladies intestinales › Tumeurs de l'intestin › Tumeurs du côlon › Imaging standardisation in metastatic...